Literature DB >> 11360222

Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome.

P Abboud1, V Lemée, G Gargala, P Brasseur, J J Ballet, F Borsa-Lebas, F Caron, L Favennec.   

Abstract

A case of metronidazole- and albendazole-resistant giardiasis in a patient with the acquired immunodeficiency syndrome was successfully treated with nitazoxanide (1.5 g twice a day for 30 days). Animal studies and in vitro assays showed that the isolate was resistant to both metronidazole and albendazole and susceptible to nitazoxanide.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11360222     DOI: 10.1086/320751

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  16 in total

Review 1.  Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.

Authors:  Vahab Ali; Tomoyoshi Nozaki
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

2.  The in vitro anti-giardial activity of extracts from plants that are used for self-medication by AIDS patients in southern Thailand.

Authors:  N Sawangjaroen; S Subhadhirasakul; S Phongpaichit; C Siripanth; K Jamjaroen; K Sawangjaroen
Journal:  Parasitol Res       Date:  2004-11-18       Impact factor: 2.289

3.  Short course combination therapy for giardiasis after nitroimidazole failure.

Authors:  Rogelio Lopez-Velez; Carolina Batlle; Carolina Jiménez; Miriam Navarro; Francesca Norman; Jose Perez-Molina
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

Review 4.  Understanding drug resistance in human intestinal protozoa.

Authors:  Hend Aly El-Taweel
Journal:  Parasitol Res       Date:  2015-03-19       Impact factor: 2.289

5.  Divergent Transcriptional Responses to Physiological and Xenobiotic Stress in Giardia duodenalis.

Authors:  Brendan R E Ansell; Malcolm J McConville; Louise Baker; Pasi K Korhonen; Samantha J Emery; Staffan G Svärd; Robin B Gasser; Aaron R Jex
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

6.  In vitro parasiticidal effect of Nitazoxanide against Echinococcus multilocularis metacestodes.

Authors:  Marianne Stettler; Renate Fink; Mirjam Walker; Bruno Gottstein; Timothy G Geary; Jean François Rossignol; Andrew Hemphill
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

7.  Treatment of giardiasis: current status and future directions.

Authors:  Richard R Watkins; Lars Eckmann
Journal:  Curr Infect Dis Rep       Date:  2014-02       Impact factor: 3.725

8.  Nitazoxanide in the Treatment of Intestinal Parasitic Infections in Children: A Systematic Review and Meta-Analysis.

Authors:  Jinyi Li; Hongyu Kuang; Xue Zhan
Journal:  Indian J Pediatr       Date:  2019-12-12       Impact factor: 1.967

Review 9.  Current treatment options for Dientamoeba fragilis infections.

Authors:  Noriyuki Nagata; Deborah Marriott; John Harkness; John T Ellis; Damien Stark
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-09-03       Impact factor: 4.077

10.  Incidental Diagnosis of Duodenal Giardiasis.

Authors:  M Ammar Kalas; Ahmed Alduaij; Amer A Alkhatib
Journal:  Cureus       Date:  2021-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.